Lewy body disease or diseases with Lewy bodies?
K Menšíková, R Matěj, C Colosimo, R Rosales… - npj Parkinson's …, 2022 - nature.com
The current nosological concept of α-synucleinopathies characterized by the presence of
Lewy bodies (LBs) includes Parkinson's disease (PD), Parkinson's disease dementia (PDD) …
Lewy bodies (LBs) includes Parkinson's disease (PD), Parkinson's disease dementia (PDD) …
[HTML][HTML] Approach to cognitive impairment in Parkinson's disease
Cognitive dysfunction is common in Parkinson's disease (PD) and predicts poor clinical
outcomes. It is associated primarily with pathologic involvement of basal forebrain …
outcomes. It is associated primarily with pathologic involvement of basal forebrain …
Diagnostic performance of RO948 F 18 tau positron emission tomography in the differentiation of Alzheimer disease from other neurodegenerative disorders
A Leuzy, R Smith, R Ossenkoppele, A Santillo… - JAMA …, 2020 - jamanetwork.com
Importance The diagnostic performance of second-generation tau positron emission
tomographic (PET) tracers is not yet known. Objective To examine the novel tau PET tracer …
tomographic (PET) tracers is not yet known. Objective To examine the novel tau PET tracer …
Timing variability and midfrontal~ 4 Hz rhythms correlate with cognition in Parkinson's disease
Patients with Parkinson's disease (PD) can have significant cognitive dysfunction; however,
the mechanisms for these cognitive symptoms are unknown. Here, we used scalp …
the mechanisms for these cognitive symptoms are unknown. Here, we used scalp …
Cognitive impairment and dementia in Parkinson disease
JG Goldman, E Sieg - Clinics in geriatric medicine, 2020 - geriatric.theclinics.com
Cognitive impairment is a frequent nonmotor symptom in Parkinson disease (PD), often
associated with poor outcomes and reduced quality of life. 1–3 Cognitive impairment in PD …
associated with poor outcomes and reduced quality of life. 1–3 Cognitive impairment in PD …
[HTML][HTML] Parkinson's disease: a comprehensive analysis of fungi and bacteria in brain tissue
D Pisa, R Alonso, L Carrasco - International Journal of Biological …, 2020 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is characterized by motor disorders and the destruction of
dopaminergic neurons in the substantia nigra pars compacta. In addition to motor disability …
dopaminergic neurons in the substantia nigra pars compacta. In addition to motor disability …
Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies
G Palermo, E Del Prete, U Bonuccelli, R Ceravolo - Journal of Neurology, 2020 - Springer
Differential diagnosis between Parkinson's disease, dementia with Lewy bodies and
multiple system atrophy can be difficult, especially because in early phase they might …
multiple system atrophy can be difficult, especially because in early phase they might …
Parkinson's disease and parkinsonism.
AI Tröster - 2023 - psycnet.apa.org
Parkinsonism and Parkinson's disease are not synonymous. Parkinsonism refers classically
to a triad of motor symptoms (bradykinesia, rigidity, and tremor), but gait instability is also …
to a triad of motor symptoms (bradykinesia, rigidity, and tremor), but gait instability is also …
Differences in cognitive profiles between Lewy body and Parkinson's disease dementia
Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) not only differ
for the time of onset of cognitive deficits but also present variability in affected functions …
for the time of onset of cognitive deficits but also present variability in affected functions …
Practical use of DAT SPECT imaging in diagnosing dementia with Lewy bodies: a US perspective of current guidelines and future directions
Background Diagnosing Dementia with Lewy Bodies (DLB) remains a challenge in clinical
practice. The use of 123I-ioflupane (DaTscan™) SPECT imaging, which detects reduced …
practice. The use of 123I-ioflupane (DaTscan™) SPECT imaging, which detects reduced …